Invivo Diagnostics

Leaders in multiple microbiome diagnostics.

Multiple Microbiome Diagnostics

qPCR microbiome tests with ELISA health markers for comprehensive ecosystem health assessments from our microbiome lab in Bristol.

View product

GI EcologiX™

The ultimate gut health and microbiome stool test, providing a comprehensive analysis of the GI ecosystem and chronic disease-related biomarkers
View product

Vaginal EcologiX

A ground-breaking clinical tool for the assessment of the vaginal microbiome – a key ecosystem for female health and reproductive optimisation.
View product

Oral EcologiX

A ground-breaking clinical tool for the assessment of the oral microbiome – a key ecosystem in the gut-brain connection, and for cardiovascular and female reproductive health.

In 2018 Invivo invested in starting Invivo Diagnostics, a microbiome and biotech laboratory based out of Bristol in the UK. The laboratory specialises in multiple microbiome diagnostics for the assessment of gastrointestinal, vaginal, and oral ecosystems.

Invivo Diagnostics has built an  incredible team  of microbiologists, alongside a global scientific advisory board. Along with consultants such as Dr Jason Hawrelak, they have helped craft the science, the target markers, and the clinical utility of the profiles. We are incredibly proud and excited to provide you with three comprehensive microbiome tests from a specialist CQC laboratory.

Humphrey Bacchus 
MD | Invivo Healthcare
Founder | Invivo Diagnostics

READ MORE

A Lab You Can Trust

UK Laboratory ✓ 
CQC Approved  ✓ 
Scientific Advisory Board  ✓ 
B Corp   ✓  
Carbon Neutral  ✓ 

Log in to buy your EcologiX microbiome test

log in
“We are as proud as we are humbled at our opportunity to be part of an incredibly talented and flourishing UK microbiome sector and to take our science onto a global stage.”
Humphrey Bacchus
Methodology & Accuracy Measures

Invivo Diagnostics Laboratory uses culture-independent methods for analysis: quantitative real-time polymerase chain reaction (qPCR) and enzyme linked immunosorbent assay (ELISA) for the protein health markers.

What is different is their two-step quality and control process: standardisation of the samples to a  particular concentration  of extracted DNA, and the use of an endogenous control  to normalise the data and report on the relative abundance.

Normalisation & Relative Quantification = Personalised Data

The data is represented as a relative abundance of the target microbes to the ‘general’ microbial population available in the extracted DNA.  We  do this by  using  an endogenous control  – the conserved portion of DNA for all microorganisms – to measure  your  ‘general’  microbial load within  the sample.

This is your baseline –  a representation of the  general population  of  your  gut microbiome  in the given sample.  This is the most  precise  way of using DNA to establish microbial gene  abundance, as is used throughout research.

Find out why this is important

Scientific Advisory Board

Meet the team